Announcement Title
Change - Announcement of Cessation
Date &Time of Broadcast
03-Apr-2024 22:37:20
Announcement Sub Title
Cessation As Independent Director
Announcement Reference
Submitted By (Co./ Ind. Name)
Warangkana Tewapunkul
Legal Corporate Manager and Company Secretary
Description (Please provide a detailed description of the event in the box below)
Please refer to details below.

Additional Details

Name Of Person
Dr. Jan Jozef Skorupa
Is effective date of cessation known?
If yes, please provide the date
Detailed Reason (s) for cessation
As part of the board renewal plan and following changes in the SGX Listing Rules, Dr Jan Jozef Skorupa having served as an Independent Director for more than 10 years, will step down from the Board with effect from 25 April 2024. Upon his cessation as Independent Director, he will relinquish his positions as Chairman of the Nomination Committee and a member of the Audit Committee and Remuneration Committee.
Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting?
Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer?
Any other relevant information to be provided to shareholders of the listed issuer?
Date of Appointment to current position
Does the AC have a minimum of 3 members (taking into account this cessation)?
Number of Independent Directors currently resident in Singapore (taking into account this cessation)
Number of cessations of appointments specified in Listing Rule 704 (7) or Catalist Rule 704 (6) over the past 12 months
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
Non-Executive and Independent Director
Chairman of the Nomination Committee
Member of the Audit Committee
Member of the Remuneration Committee
Role and responsibilities
He served as a Non-Executive and Independent Director, the Chairman of the Nomination Committee, and a member of the Audit Committee and the Remuneration Committee.
Familial relationship with any director and/ or substantial shareholder of the listed issuer or of any of its principal subsidiaries
Shareholding interest in the listed issuer and its subsidiaries?
Shareholding Details
Dr. Jan holds 1,000 shares in the Company - 0.00007% direct interest and 0% deemed interest.
Past (for the last 5 years)
Managing Director, Clesol Co., Ltd.